Table of Content

1. Preface
? ? 1.1. Market Definition and Scope
? ? 1.2. Market Segmentation
? ? 1.3. Key Research Objectives
? ? 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Chronic Kidney Disease (CKD) Drugs Market

4. Market Overview
? ? 4.1. Introduction
? ? ? ? 4.1.1. Product Definition
? ? ? ? 4.1.2. Industry Evolution/Developments
? ? 4.2. Overview
? ? 4.3. Market Dynamics
? ? ? ? 4.3.1. Drivers
? ? ? ? 4.3.2. Restraints
? ? ? ? 4.3.3. Opportunities
? ? 4.4. Global Chronic Kidney Disease (CKD) Drugs Market Analysis and Forecast, 2020-2034

5. Key Insights
? ? 5.1. Pipeline Analysis
? ? 5.2. Key Product/Brand Analysis
? ? 5.3. Key Mergers & Acquisitions
? ? 5.4. COVID-19 Pandemic Impact on Industry

6. Global Chronic Kidney Disease (CKD) Drugs Market Analysis and Forecast, by Drug Class
? ? 6.1. Introduction & Definition
? ? 6.2. Key Findings/Developments
? ? 6.3. Market Value Forecast, by Drug Class, 2020-2034
? ? ? ? 6.3.1. ACE Inhibitors
? ? ? ? 6.3.2. Angiotensin-II Receptor Blockers
? ? ? ? 6.3.3. Calcium Channel Blockers
? ? ? ? 6.3.4. Beta Blockers
? ? ? ? 6.3.5. Erythropoiesis-stimulating Agents (ESAs)
? ? ? ? 6.3.6. Diuretics
? ? ? ? 6.3.7. Others
? ? 6.4. Market Attractiveness Analysis, by Drug Class

7. Global Chronic Kidney Disease (CKD) Drugs Market Analysis and Forecast, by End-user
? ? 7.1. Introduction & Definition
? ? 7.2. Key Findings/Developments
? ? 7.3. Market Value Forecast, by End-user, 2020-2034
? ? ? ? 7.3.1. Hospitals
? ? ? ? 7.3.2. Specialty Clinics
? ? 7.4. Market Attractiveness Analysis, by End-user

8. Global Chronic Kidney Disease (CKD) Drugs Market Analysis and Forecast, by Region
? ? 8.1. Key Findings
? ? 8.2. Market Value Forecast, by Region, 2020-2034
? ? ? ? 8.2.1. North America
? ? ? ? 8.2.2. Europe
? ? ? ? 8.2.3. Asia Pacific
? ? ? ? 8.2.4. Latin America
? ? ? ? 8.2.5. Middle East & Africa
? ? 8.3. Market Attractiveness Analysis, by Region

9. North America Chronic Kidney Disease (CKD) Drugs Market Analysis and Forecast
? ? 9.1. Introduction
? ? 9.2. Key Findings
? ? 9.3. Market Value Forecast, by Drug Class, 2020-2034
? ? ? ? 9.3.1. ACE Inhibitors
? ? ? ? 9.3.2. Angiotensin-II Receptor Blockers
? ? ? ? 9.3.3. Calcium Channel Blockers
? ? ? ? 9.3.4. Beta Blockers
? ? ? ? 9.3.5. Erythropoiesis-stimulating Agents (ESAs)
? ? ? ? 9.3.6. Diuretics
? ? ? ? 9.3.7. Others
? ? 9.4. Market Value Forecast, by End-user, 2020-2034
? ? ? ? 9.4.1. Hospitals
? ? ? ? 9.4.2. Specialty Clinics
? ? 9.5. Market Value Forecast, by Country, 2020-2034
? ? ? ? 9.5.1. U.S.
? ? ? ? 9.5.2. Canada
? ? 9.6. Market Attractiveness Analysis
? ? ? ? 9.6.1. By Drug Class
? ? ? ? 9.6.2. By End-user
? ? ? ? 9.6.3. By Country

10. Europe Chronic Kidney Disease (CKD) Drugs Market Analysis and Forecast
? ? 10.1. Introduction
? ? 10.2. Key Findings
? ? 10.3. Market Value Forecast, by Drug Class, 2020-2034
? ? ? ? 10.3.1. ACE Inhibitors
? ? ? ? 10.3.2. Angiotensin-II Receptor Blockers
? ? ? ? 10.3.3. Calcium Channel Blockers
? ? ? ? 10.3.4. Beta Blockers
? ? ? ? 10.3.5. Erythropoiesis-stimulating Agents (ESAs)
? ? ? ? 10.3.6. Diuretics
? ? ? ? 10.3.7. Others
? ? 10.4. Market Value Forecast, by End-user, 2020-2034
? ? ? ? 10.4.1. Hospitals
? ? ? ? 10.4.2. Specialty Clinics
? ? 10.5. Market Value Forecast, by Country/Sub-region, 2020-2034
? ? ? ? 10.5.1. Germany
? ? ? ? 10.5.2. U.K.
? ? ? ? 10.5.3. France
? ? ? ? 10.5.4. Italy
? ? ? ? 10.5.5. Spain
? ? ? ? 10.5.6. Rest of Europe
? ? 10.6. Market Attractiveness Analysis
? ? ? ? 10.6.1. By Drug Class
? ? ? ? 10.6.2. By End-user
? ? ? ? 10.6.3. By Country/Sub-region

11. Asia Pacific Chronic Kidney Disease (CKD) Drugs Market Analysis and Forecast
? ? 11.1. Introduction
? ? 11.2. Key Findings
? ? 11.3. Market Value Forecast, by Drug Class, 2020-2034
? ? ? ? 11.3.1. ACE Inhibitors
? ? ? ? 11.3.2. Angiotensin-II Receptor Blockers
? ? ? ? 11.3.3. Calcium Channel Blockers
? ? ? ? 11.3.4. Beta Blockers
? ? ? ? 11.3.5. Erythropoiesis-stimulating Agents (ESAs)
? ? ? ? 11.3.6. Diuretics
? ? ? ? 11.3.7. Others
? ? 11.4. Market Value Forecast, by End-user, 2020-2034
? ? ? ? 11.4.1. Hospitals
? ? ? ? 11.4.2. Specialty Clinics
? ? 11.5. Market Value Forecast, by Country/Sub-region, 2020-2034
? ? ? ? 11.5.1. China
? ? ? ? 11.5.2. Japan
? ? ? ? 11.5.3. India
? ? ? ? 11.5.4. Australia & New Zealand
? ? ? ? 11.5.5. Rest of Asia Pacific
? ? 11.6. Market Attractiveness Analysis
? ? ? ? 11.6.1. By Drug Class
? ? ? ? 11.6.2. By End-user
? ? ? ? 11.6.3. By Country/Sub-region

12. Latin America Chronic Kidney Disease (CKD) Drugs Market Analysis and Forecast
? ? 12.1. Introduction
? ? 12.2. Key Findings
? ? 12.3. Market Value Forecast, by Drug Class, 2020-2034
? ? ? ? 12.3.1. ACE Inhibitors
? ? ? ? 12.3.2. Angiotensin-II Receptor Blockers
? ? ? ? 12.3.3. Calcium Channel Blockers
? ? ? ? 12.3.4. Beta Blockers
? ? ? ? 12.3.5. Erythropoiesis-stimulating Agents (ESAs)
? ? ? ? 12.3.6. Diuretics
? ? ? ? 12.3.7. Others
? ? 12.4. Market Value Forecast, by End-user, 2020-2034
? ? ? ? 12.4.1. Hospitals
? ? ? ? 12.4.2. Specialty Clinics
? ? 12.5. Market Value Forecast, by Country/Sub-region, 2020-2034
? ? ? ? 12.5.1. Brazil
? ? ? ? 12.5.2. Mexico
? ? ? ? 12.5.3. Rest of Latin America
? ? 12.6. Market Attractiveness Analysis
? ? ? ? 12.6.1. By Drug Class
? ? ? ? 12.6.2. By End-user
? ? ? ? 12.6.3. By Country/Sub-region

13. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Market Analysis and Forecast
? ? 13.1. Introduction
? ? 13.2. Key Findings
? ? 13.3. Market Value Forecast, by Drug Class, 2020-2034
? ? ? ? 13.3.1. ACE Inhibitors
? ? ? ? 13.3.2. Angiotensin-II Receptor Blockers
? ? ? ? 13.3.3. Calcium Channel Blockers
? ? ? ? 13.3.4. Beta Blockers
? ? ? ? 13.3.5. Erythropoiesis-stimulating Agents (ESAs)
? ? ? ? 13.3.6. Diuretics
? ? ? ? 13.3.7. Others
? ? 13.4. Market Value Forecast, by End-user, 2020-2034
? ? ? ? 13.4.1. Hospitals
? ? ? ? 13.4.2. Specialty Clinics
? ? 13.5. Market Value Forecast, by Country/Sub-region, 2020-2034
? ? ? ? 13.5.1. GCC Countries
? ? ? ? 13.5.2. South Africa
? ? ? ? 13.5.3. Rest of Middle East & Africa
? ? 13.6. Market Attractiveness Analysis
? ? ? ? 13.6.1. By Drug Class
? ? ? ? 13.6.2. By End-user
? ? ? ? 13.6.3. By Country/Sub-region
14. Competition Landscape
? ? 14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
? ? 14.2. Market Share Analysis, by Company (2023)
? ? 14.3. Company Profiles
? ? ? ? 14.3.1. F. Hoffmann-La Roche Ltd.
? ? ? ? ? ? 14.3.1.1. Company Overview
? ? ? ? ? ? 14.3.1.2. Product Portfolio
? ? ? ? ? ? 14.3.1.3. SWOT Analysis
? ? ? ? ? ? 14.3.1.4. Financial Overview
? ? ? ? ? ? 14.3.1.5. Strategic Overview
? ? ? ? 14.3.2. Pfizer, Inc.
? ? ? ? ? ? 14.3.2.1. Company Overview
? ? ? ? ? ? 14.3.2.2. Product Portfolio
? ? ? ? ? ? 14.3.2.3. SWOT Analysis
? ? ? ? ? ? 14.3.2.4. Financial Overview
? ? ? ? ? ? 14.3.2.5. Strategic Overview
? ? ? ? 14.3.3. Sanofi
? ? ? ? ? ? 14.3.3.1. Company Overview
? ? ? ? ? ? 14.3.3.2. Product Portfolio
? ? ? ? ? ? 14.3.3.3. SWOT Analysis
? ? ? ? ? ? 14.3.3.4. Financial Overview
? ? ? ? ? ? 14.3.3.5. Strategic Overview
? ? ? ? 14.3.4. GSK plc
? ? ? ? ? ? 14.3.4.1. Company Overview
? ? ? ? ? ? 14.3.4.2. Product Portfolio
? ? ? ? ? ? 14.3.4.3. SWOT Analysis
? ? ? ? ? ? 14.3.4.4. Financial Overview
? ? ? ? ? ? 14.3.4.5. Strategic Overview
? ? ? ? 14.3.5. Kissei Pharmaceutical Co., Ltd.
? ? ? ? ? ? 14.3.5.1. Company Overview
? ? ? ? ? ? 14.3.5.2. Product Portfolio
? ? ? ? ? ? 14.3.5.3. SWOT Analysis
? ? ? ? ? ? 14.3.5.4. Financial Overview
? ? ? ? ? ? 14.3.5.5. Strategic Overview
? ? ? ? 14.3.6. AbbVie Inc.
? ? ? ? ? ? 14.3.6.1. Company Overview
? ? ? ? ? ? 14.3.6.2. Product Portfolio
? ? ? ? ? ? 14.3.6.3. SWOT Analysis
? ? ? ? ? ? 14.3.6.4. Financial Overview
? ? ? ? ? ? 14.3.6.5. Strategic Overview
? ? ? ? 14.3.7. Akebia Therapeutics, Inc.
? ? ? ? ? ? 14.3.7.1. Company Overview
? ? ? ? ? ? 14.3.7.2. Product Portfolio
? ? ? ? ? ? 14.3.7.3. SWOT Analysis
? ? ? ? ? ? 14.3.7.4. Financial Overview
? ? ? ? ? ? 14.3.7.5. Strategic Overview
? ? ? ? 14.3.8. AstraZeneca
? ? ? ? ? ? 14.3.8.1. Company Overview
? ? ? ? ? ? 14.3.8.2. Product Portfolio
? ? ? ? ? ? 14.3.8.3. SWOT Analysis
? ? ? ? ? ? 14.3.8.4. Financial Overview
? ? ? ? ? ? 14.3.8.5. Strategic Overview
? ? ? ? 14.3.9. Amgen Inc.
? ? ? ? ? ? 14.3.9.1. Company Overview
? ? ? ? ? ? 14.3.9.2. Product Portfolio
? ? ? ? ? ? 14.3.9.3. SWOT Analysis
? ? ? ? ? ? 14.3.9.4. Financial Overview
? ? ? ? ? ? 14.3.9.5. Strategic Overview
? ? ? ? 14.3.10. Teva Pharmaceutical Industries Ltd.
? ? ? ? ? ? 14.3.10.1. Company Overview
? ? ? ? ? ? 14.3.10.2. Product Portfolio
? ? ? ? ? ? 14.3.10.3. SWOT Analysis
? ? ? ? ? ? 14.3.10.4. Financial Overview
? ? ? ? ? ? 14.3.10.5. Strategic Overview



List of Figures

List of Figures

Figure 01: Global Chronic Kidney Disease (CKD) Drugs Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034

Figure 02: Global Chronic Kidney Disease (CKD) Drugs Market Revenue (US$ Mn), by Drug Class, 2023

Figure 03: Global Chronic Kidney Disease (CKD) Drugs Market Value Share, by Drug Class, 2023

Figure 04: Global Chronic Kidney Disease (CKD) Drugs Market Revenue (US$ Mn), by End-user, 2023

Figure 05: Global Chronic Kidney Disease (CKD) Drugs Market Value Share, by End-user, 2023

Figure 06: Global Chronic Kidney Disease (CKD) Drugs Market Value Share, by Region, 2023

Figure 07: Global Chronic Kidney Disease (CKD) Drugs Market Value (US$ Mn) Forecast, 2020-2034

Figure 08: Global Chronic Kidney Disease (CKD) Drugs Market Value Share Analysis, by Drug Class, 2023 and 2034

Figure 09: Global Chronic Kidney Disease (CKD) Drugs Market Attractiveness Analysis, by Drug Class, 2024-2034

Figure 10: Global Chronic Kidney Disease (CKD) Drugs Market Value Share Analysis, by End-user, 2023 and 2034

Figure 11: Global Chronic Kidney Disease (CKD) Drugs Market Attractiveness Analysis, by End-user, 2024-2034

Figure 12: Global Chronic Kidney Disease (CKD) Drugs Market Value Share Analysis, by Region, 2023 and 2034

Figure 13: Global Chronic Kidney Disease (CKD) Drugs Market Attractiveness Analysis, by Region, 2024-2034

Figure 14: North America Chronic Kidney Disease (CKD) Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 15: North America Chronic Kidney Disease (CKD) Drugs Market Attractiveness Analysis, by Country, 2024-2034

Figure 16: North America Chronic Kidney Disease (CKD) Drugs Market Value Share Analysis, by Country, 2023 and 2034

Figure 17: North America Chronic Kidney Disease (CKD) Drugs Market Value Share Analysis, by Drug Class, 2023 and 2034

Figure 18: North America Chronic Kidney Disease (CKD) Drugs Market Value Share Analysis, by End-user, 2023 and 2034

Figure 19: North America Chronic Kidney Disease (CKD) Drugs Market Attractiveness Analysis, by Drug Class, 2024-2034

Figure 20: North America Chronic Kidney Disease (CKD) Drugs Market Attractiveness Analysis, by End-user, 2024-2034

Figure 21: Europe Chronic Kidney Disease (CKD) Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 22: Europe Chronic Kidney Disease (CKD) Drugs Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 23: Europe Chronic Kidney Disease (CKD) Drugs Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 24: Europe Chronic Kidney Disease (CKD) Drugs Market Value Share Analysis, by Drug Class, 2023 and 2034

Figure 25: Europe Chronic Kidney Disease (CKD) Drugs Market Value Share Analysis, by End-user, 2023 and 2034

Figure 26: Europe Chronic Kidney Disease (CKD) Drugs Market Attractiveness Analysis, by Drug Class, 2024-2034

Figure 27: Europe Chronic Kidney Disease (CKD) Drugs Market Attractiveness Analysis, by End-user, 2024-2034

Figure 28: Asia Pacific Chronic Kidney Disease (CKD) Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 29: Asia Pacific Chronic Kidney Disease (CKD) Drugs Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 30: Asia Pacific Chronic Kidney Disease (CKD) Drugs Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 31: Asia Pacific Chronic Kidney Disease (CKD) Drugs Market Value Share Analysis, by Drug Class, 2023 and 2034

Figure 32: Asia Pacific Chronic Kidney Disease (CKD) Drugs Market Value Share Analysis, by End-user, 2023 and 2034

Figure 33: Asia Pacific Chronic Kidney Disease (CKD) Drugs Market Attractiveness Analysis, by Drug Class, 2024-2034

Figure 34: Asia Pacific Chronic Kidney Disease (CKD) Drugs Market Attractiveness Analysis, by End-user, 2024-2034

Figure 35: Latin America Chronic Kidney Disease (CKD) Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 36: Latin America Chronic Kidney Disease (CKD) Drugs Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 37: Latin America Chronic Kidney Disease (CKD) Drugs Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 38: Latin America Chronic Kidney Disease (CKD) Drugs Market Value Share Analysis, by Drug Class, 2023 and 2034

Figure 39: Latin America Chronic Kidney Disease (CKD) Drugs Market Value Share Analysis, by End-user, 2023 and 2034

Figure 40: Latin America Chronic Kidney Disease (CKD) Drugs Market Attractiveness Analysis, by Drug Class, 2024-2034

Figure 41: Latin America Chronic Kidney Disease (CKD) Drugs Market Attractiveness Analysis, by End-user, 2024-2034

Figure 42: Middle East & Africa Chronic Kidney Disease (CKD) Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 43: Middle East & Africa Chronic Kidney Disease (CKD) Drugs Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 44: Middle East & Africa Chronic Kidney Disease (CKD) Drugs Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 45: Middle East & Africa Chronic Kidney Disease (CKD) Drugs Market Value Share Analysis, by Drug Class, 2023 and 2034

Figure 46: Middle East & Africa Chronic Kidney Disease (CKD) Drugs Market Value Share Analysis, by End-user, 2023 and 2034

Figure 47: Middle East & Africa Chronic Kidney Disease (CKD) Drugs Market Attractiveness Analysis, by Drug Class, 2024-2034

Figure 48: Middle East & Africa Chronic Kidney Disease (CKD) Drugs Market Attractiveness Analysis, by End-user, 2024-2034

List of Tables

List of Tables

Table 01: Global Chronic Kidney Disease (CKD) Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2020-2034

Table 02: Global Chronic Kidney Disease (CKD) Drugs Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 03: Global Chronic Kidney Disease (CKD) Drugs Market Size (US$ Mn) Forecast, by Region, 2020-2034

Table 04: North America Chronic Kidney Disease (CKD) Drugs Market Size (US$ Mn) Forecast, by Country, 2020-2034

Table 05: North America Chronic Kidney Disease (CKD) Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2020-2034

Table 06: North America Chronic Kidney Disease (CKD) Drugs Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 07: Europe Chronic Kidney Disease (CKD) Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 08: Europe Chronic Kidney Disease (CKD) Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2020-2034

Table 09: Europe Chronic Kidney Disease (CKD) Drugs Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 10: Asia Pacific Chronic Kidney Disease (CKD) Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 11: Asia Pacific Chronic Kidney Disease (CKD) Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2020-2034

Table 12: Asia Pacific Chronic Kidney Disease (CKD) Drugs Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 13: Latin America Chronic Kidney Disease (CKD) Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 14: Latin America Chronic Kidney Disease (CKD) Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2020-2034

Table 15: Latin America Chronic Kidney Disease (CKD) Drugs Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 16: Middle East & Africa Chronic Kidney Disease (CKD) Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 17: Middle East & Africa Chronic Kidney Disease (CKD) Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2020-2034

Table 18: Middle East & Africa Chronic Kidney Disease (CKD) Drugs Market Size (US$ Mn) Forecast, by End-user, 2020-2034